BRIEF-Mimedx Group says Osiris data review has "substantive deficiencies and serious flaws" By: Reuters: Company News May 03, 2016 at 09:16 AM EDT * Mimedx group inc says Osiris data review has "substantive deficiencies and serious flaws" Read More >> Related Stocks: Mimedx Group Inc Osiris Therapeutics